Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome

Table 1

Clinical and laboratory characteristics of controls and patients of NAFLD.

	Patients of NAFLD ()	Control group ()
	/, %	/, %
Age (years)
Gender
Male	16 (40%)	10 (50%)
Female	24 (60%)	10 (50%)
BMI (kg/m^2)
Waist circumference(cm)
Systolic pressure (mmHg)
Diastolic pressure (mmHg)
Fasting blood glucose (mg/dL)
HbA1c (%)
Triglyceride (mg/dL)
Total cholesterol (mg/dL)
LDL (mg/dL)
HDL (mg/dL)
CRP (mg/L)
AST (U/L)
ALT (U/L)
GGT (U/L)
Endocan (pg/mL)
FLI
HSI
NAFLD grade
0	0 (0%)	20 (100%)
1	5 (12.5%)	0 (0%)
2	15 (37.5%)	0 (0%)
3	20 (50.0%)	0 (0%)

Mann-Whitney , Student’s , and Fisher’s exact test. Statistical significance: , . BMI: body mass index; HOMA-IR: homeostasis model assessment of insulin resistance; LDL: low-density lipoprotein; HDL: high-density lipoprotein; CRP: C-reactive protein; AST: aspartate transaminase; ALT: alanine transaminase; GGT: gamma-glutamyl transpeptidase; FLI: fatty liver index; HSI: hepatic steatosis index.